financetom
Business
financetom
/
Business
/
Schlumberger's Strategic Expansion Pays Off: Surpasses Q1 Topline Expectations, Commits To $7B Shareholder Return
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Schlumberger's Strategic Expansion Pays Off: Surpasses Q1 Topline Expectations, Commits To $7B Shareholder Return
Apr 19, 2024 7:06 AM

Schlumberger N.V. ( SLB ) reported a first-quarter 2024 revenue increase of 13% year-over-year to $8.707 billion, beating the consensus of $8.689 billion.

The company stated that almost half of the year-on-year revenue increase came from the Aker subsea business, which was added as part of our OneSubsea joint venture in the fourth quarter of 2023.

Related: Schlumberger Expands Carbon Capture Reach Through Aker ACC Deal: Details

Revenue by Division: Digital & Integration $953 million (+7% Y/Y); Reservoir Performance $1.725 billion (+15% Y/Y); Well Construction $3.368 billion (+3% Y/Y), and Production Systems $2.82 billion (+28% Y/Y).

International revenue grew 18% Y/Y, with YoY growth of 29% in the Middle East & Asia and 18% in Europe & Africa. North American market revenue declined 6% Y/Y.

Adjusted EPS increased 19% Y/Y to $0.75, which aligned with the consensus.

Related: Schlumberger Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Adjusted EBITDA was $2.06 billion for the quarter, an increase of 15% Y/Y, and margin expanded 51 bps to 23.6%. The pretax segment operating margin expanded by 95 bps for the quarter to 18.9%.

Operating cash flow for the quarter totaled $327 million compared to $330 million a year ago. Free cash flow was negative $(222 million.

Dividend: SLB declared a quarterly cash dividend of $0.275 per share, payable on July 11, 2024, to stockholders of record on June 5, 2024.

“We remain confident in our global revenue growth outlook for 2024, with softness in North America being offset by upside in the international markets,” CEO Olivier Le Peuch commented.

“Based on our strong start to the year, confidence in our ability to generate robust cash flows, and the anticipated contribution of the announced ChampionX acquisition, we are targeting to return $7 billion to shareholders over the next two years. This represents a target for returns to shareholders of $3 billion in 2024 and $4 billion in 2025.”

Related: ChampionX, Schlumberger Shares Move In Opposite Directions After $8B Deal Announcement

During the quarter, SLB repurchased 5.4 million shares at an average price of $50.13 per share for $270 million.

Price Action: SLB shares are trading lower by 1.87% at $49.99 at the last check Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk Says Further Work Needed to Balance Monlunabant's Efficacy, Safety in Obesity
Novo Nordisk Says Further Work Needed to Balance Monlunabant's Efficacy, Safety in Obesity
Sep 20, 2024
09:59 AM EDT, 09/20/2024 (MT Newswires) -- Novo Nordisk ( NVO ) said Friday that a phase 2a trial of monlunabant in obesity showed that all doses achieved a statistically significant weight loss, but reports of mild to moderate neuropsychiatric side effects were more frequent and dose-dependent with the investigational drug compared with placebo. Martin Holst Lange, head of development,...
Nike Appointment of Elliot Hill as CEO Seen as Focus on Cultural Revamp, Oppenheimer Says
Nike Appointment of Elliot Hill as CEO Seen as Focus on Cultural Revamp, Oppenheimer Says
Sep 20, 2024
12:36 PM EDT, 09/20/2024 (MT Newswires) -- Nike's ( NKE ) appointment of Elliott Hill as CEO is a strong signal of a deeper commitment from the board to turn around the company, focus on both cultural and operational improvements, Oppenheimer said in a note emailed Friday. Growth in Nike's ( NKE ) consumer segment is anticipated to benefit from...
FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
Sep 20, 2024
12:25 PM EDT, 09/20/2024 (MT Newswires) -- The Federal Trade Commission on Friday said it has filed suit against the three biggest prescription drug benefit managers, or PBMs, for allegedly inflating the list prices of insulin drugs artificially. The complaint alleges that CVS Health's ( CVS ) Caremark, Cigna's ( CI ) Express Scripts and UnitedHealth Group's ( UNH )...
Global Engine Group Shares Rise After Nasdaq Debut at Higher-Than-IPO Price
Global Engine Group Shares Rise After Nasdaq Debut at Higher-Than-IPO Price
Sep 20, 2024
01:02 PM EDT, 09/20/2024 (MT Newswires) -- Global Engine Group ( GLE ) shares were up nearly 11% in recent trading Friday after the company's stock marked its Nasdaq debut at higher than the $4-per-share initial public offering price. The company's shares were trading at $4.42 per share in recent trading after opening at $5.15. The offering is expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved